| 1 |
35226770 | Biology of IDH mutant cholangiocarcinoma. | 2022 May |
1 |
| 2 |
35609569 | Dysfunctional dendritic cells limit antigen-specific T cell response in glioma. | 2022 May 24 |
1 |
| 3 |
34183306 | IDH-Mutant Brain Tumors Hit the Achilles' Heel of Macrophages with R-2-Hydroxyglutarate. | 2021 Aug |
2 |
| 4 |
34188585 | Efficacy and Safety Profile of Ivosidenib in the Management of Patients with Acute Myeloid Leukemia (AML): An Update on the Emerging Evidence. | 2021 |
1 |
| 5 |
32882760 | All-Trans Retinoic Acid Synergizes with Enasidenib to Induce Differentiation of IDH2-Mutant Acute Myeloid Leukemia Cells. | 2020 Sep |
2 |
| 6 |
32955829 | Enasidenib and ivosidenib in AML. | 2020 Oct |
1 |
| 7 |
30643428 | Evaluating ivosidenib for the treatment of relapsed/refractory AML: design, development, and place in therapy. | 2019 |
1 |
| 8 |
29249359 | R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling. | 2018 Jan 11 |
1 |
| 9 |
28132785 | Allosteric Mutant IDH1 Inhibitors Reveal Mechanisms for IDH1 Mutant and Isoform Selectivity. | 2017 Mar 7 |
1 |
| 10 |
28319047 | Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ T cell accumulation in gliomas. | 2017 Apr 3 |
1 |
| 11 |
28711227 | Oncogenic Activities of IDH1/2 Mutations: From Epigenetics to Cellular Signaling. | 2017 Oct |
1 |
| 12 |
26691210 | Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma. | 2016 Feb |
2 |
| 13 |
27245312 | Evidence for Clinical Differentiation and Differentiation Syndrome in Patients With Acute Myeloid Leukemia and IDH1 Mutations Treated With the Targeted Mutant IDH1 Inhibitor, AG-120. | 2016 Aug |
1 |
| 14 |
27577048 | The oncometabolite R-2-hydroxyglutarate activates NF-κB-dependent tumor-promoting stromal niche for acute myeloid leukemia cells. | 2016 Aug 31 |
2 |
| 15 |
27624942 | The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway. | 2016 Sep 14 |
1 |
| 16 |
26007236 | Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells. | 2015 Aug |
1 |
| 17 |
26147657 | Role of isocitrate dehydrogenase 1/2 (IDH 1/2) gene mutations in human tumors. | 2015 Oct |
2 |
| 18 |
23518346 | R-2-hydroxyglutarate as the key effector of IDH mutations promoting oncogenesis. | 2013 Mar 18 |
2 |
| 19 |
23558169 | An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. | 2013 May 3 |
1 |